Results about: innovation

IRB Barcelona identifies the gene responsible for metastasis of breast cancer to the bone

A study published today in the Journal of National Cancer Institute (JNCI) by ICREA researcher Roger Gomis may be key to the early detection of patients at risk of developing metastasis to the bone

This new knowledge may accelerate the development of the first preventive treatment of bone metastasis

Inbiomotion, an IRB Barcelona spin off company and financed with venture investors Ysios Capital, has already begun clinical trials

Getting wired for innovation

Meritxell Teixidó and Núria Bayó, researchers at IRB Barcelona, have completed the first stage of the LLAVOR (seed) Programme aimed to support innovation

The researchers recommend the experience “for 99% of scientists”

ERC Proof of Concept to Angel R. Nebreda

The European Research Council awards 45 scientists with grants to commercialize their research results

The grant, worth up to €150,000, cover costs of activities to verify the innovation potential of Nebreda’s ERC Advanced Grant-funded project

Nebreda will study new breast cancer therapies

 

IRB Barcelona to participate in Bio Philadelphia 2015

The Catalan delegation headed by Biocat includes thirty-seven companies and 7 research organizations.

European project to develop an innovative therapeutic strategy against epilepsy

The European project «ECMED» (acronym of Extracellular Matrix in Epileptogenesis) is aimed to design, validate and bring into practice new innovative therapeutic strategies to further the development of a treatment and a diagnostic approach for the management of epilepsy.

The project, which has a duration of three years and a budget of € 3.5 million, is co-funded by the European Union within the Horizon 2020 research and innovation framework program through a Marie Sklodowska-Curie grant.

Biotech Iproteos, –an spin-off the IRB Barcelona and the University of Barcelona, based at Parc Científic de Barcelona– is the only Spanish partner of the consortium.

IRB Barcelona takes part in the co-session "Science is Business", a meeting space to explore new co-innovation pathways

Today the Barcelona Science Park (PCB) hosts the co-session 'Science is Business', organised by Co-societyInfonomia´s innovation platform– in collaboration with the Institute for Biomedical Research (IRB Barcelona) and PCB. The aim of the conference is to present examples of 'quick' conversion of science into business and open a space for dialogue and exchange of experiences among researchers, business people and entrepreneurs to find new ways to connect science and business, and overcome the shortcomings of typical knowledge transfer mechanisms. 

PCB hosts the co-session 'Science is Business, a meeting space to explore new co-innovation pathways